PTEN is a phosphatase that can act on both polypeptide and phosphoinositide substrates, which are frequently disrupted in multiple sporadic tumours and targeted by germline mutations in patients with cancer predisposition syndromes.6 The gene discussed is PTEN; the disease is neoplasm.